Understanding how a key protein helps other proteins fold correctly to prevent diseases like Alzheimer's.

Demystifying the interaction of UGGT, the ER folding gatekeeper, with its substrates and co-chaperone

NIH-funded research University of Massachusetts Amherst · NIH-10996959

This study is looking at a special protein called UGGT that helps other proteins fold correctly, which is important because when proteins misfold, it can lead to serious issues like Alzheimer's disease. By learning more about how UGGT works with other proteins, the researchers hope to find ways to prevent these problems.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst NIH-funded
Lab location1 site (Hadley, United States)
Project IDNIH-10996959 on NIH RePORTER

What this research studies

This research investigates the role of a protein called UGGT, which is crucial for ensuring that other proteins fold into their correct shapes. Misfolded proteins can lead to serious conditions such as Alzheimer's disease. The study will explore how UGGT interacts with its substrates and a co-chaperone protein, using various cellular and biophysical techniques. By understanding these interactions better, the research aims to shed light on the mechanisms that prevent protein misfolding.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease or related neurodegenerative conditions.

Not a fit: Patients with conditions unrelated to protein misfolding or those not at risk for Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating diseases associated with protein misfolding, such as Alzheimer's.

How similar studies have performed: Previous research has shown promising results in understanding protein folding mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

Hadley, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.